CHRISTINE TSINGOS - 13 Feb 2025 Form 4 Insider Report for Varex Imaging Corp (VREX)

Role
Director
Signature
/s/ Kimberley E. Honeysett, attorney-in-fact for Christine A. Tsingos
Issuer symbol
VREX
Transactions as of
13 Feb 2025
Net transactions value
$0
Form type
4
Filing time
14 Feb 2025, 19:05:00 UTC
Previous filing
23 May 2024
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VREX Common Stock Options Exercise +6,573 +24% 34,172 13 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VREX Deferred Stock Units Award $0 +12,123 $0.000000 12,123 13 Feb 2025 Common Stock 12,123 Direct F1, F2
transaction VREX Deferred Stock Units Options Exercise $0 -6,573 -100% $0.000000 0 13 Feb 2025 Common Stock 6,573 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Deferred Stock Unit converts into common stock on a one-for-one basis.
F2 These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.
F3 These Deferred Stock Units were issued on February 10, 2022, vested on February 9, 2023, and delivery of the vested Deferred Stock Units, in the form of common stock, occurred on February 13, 2025, the date of the Issuer's 2025 Annual Meeting.